Dr. Paul Lammers joined Triumvira Immunologics as President and Chief Executive Office on January 1, 2018. In August 2017, he successfully completed a reverse merger of Mirna Therapeutics, the Company he served as Director, President, and CEO since 2009, with Synlogic of Cambridge...
Read More →
